T1 and T2 Mapping

PLANNING COMMITTEE MEMBERS

Mark Westwood PhD; Karen Ordovas MD

Reviewed by: Anupama Rao MD (November 8, 2019)

The planners/faculty for this activity have no relevant relationships to disclose.

FACULTY

Matthias Friedrich MD; Peter Kellman PhD; Daniel Messroghli MD; Martin Ugander MD, PhD; Erica Dall'Armellina PhD; Orlando Simonetti PhD

Dr. Simonetti has grant/research support from Siemens and Cook MEDInstitute. He has received consulting fees from Vannevar Group. He is a stock shareholder (self-managed) in EXCMR, Inc.

Course Information
Course Date:
December 01, 2016
Course Objectives
  • Understand biomarkers impact on treatment and the characteristics of a good one
  • Define the current techniques of mapping and the underlying technologies
  • Understand the clinical need for native T1 Mapping
  • Learn advances in technologies effecting mapping techniques
  • Identify potential limitations and advantages when T1 Mapping
What Constitutes a Good Biomarker and Can Native T1 or ECV Fit the Bill?
Speaker Information
Matthias Friedrich  [ view bio ]
Tissue Characterization and Mapping Techniques
Speaker Information
Peter Kellman   [ view bio ]
T1- and ECV- Mapping Methods
Speaker Information
Daniel Messroghli  [ view bio ]
Post-processing: From T1 to ECV
Speaker Information
Martin Ugander  [ view bio ]
T1 Mapping in the Heart
Speaker Information
Peter Kellman   [ view bio ]
Clinical Applications of Native T1 Mapping
Speaker Information
Erica Dall'Armellina  [ view bio ]
The Future of Quantitative Imaging
Speaker Information
Orlando Simonetti  [ view bio ]
Individual topic purchase: Selected
Accreditation Council For Continuing Medical Education
Total General Hours: 2.00
The Society for Cardiovascular Magnetic Resonance is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Products
This course is no longer available for purchase.